Physician profile
Varun M Sardar
NPI 1841642162
$31,079.22
in general payments reported to CMS, 2019-2025
43 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $715 · 2021: $1,111 · 2022: $17K · 2023: $3,758 · 2024: $5,143 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,914 · Travel and Lodging: $2,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,914.47 |
| Travel and Lodging | $2,995.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,583.81 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Pressurewire |
| Abiomed | $2,288.09 | 2023-2025 | Impella |
| Penumbra, INC. | $2,146.30 | 2023-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $1,736.07 | 2021-2025 | Turbohawk, Hawkone, Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,204.27 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $994.69 | 2020-2025 | Wainua |
| Inari Medical, INC. | $664.96 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $633.02 | 2020-2025 | Avvigo Guidance System, Watchman Access System |
| Pfizer INC. | $439.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $424.50 | 2019-2025 | Camzyos |
| Livanova USA, INC. | $292.41 | 2022-2023 | Lifesparc |
| Philips North America LLC | $279.30 | 2022-2025 | Coronary Other |
| Stryker Corporation | $264.52 | 2025 | Clottriever Bold Catheter, Artix Mt, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $209.19 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $170.37 | 2024-2025 | Wegovy |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Sardar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.